Atorvastatin decreases serum levels of advanced glycation end products (AGEs) in patients with type 2 diabetes

被引:65
作者
Jinnouchi, Y.
Yamagishi, S.
Takeuchi, M.
Ishida, S.
Jinnouchi, Y.
Jinnouchi, J.
Imaizumi, T.
机构
[1] Kurume Univ, Sch Med, Dept Internal Med, Div Cardiovasc Med, Kurume, Fukuoka 8300011, Japan
[2] Hokuriku Univ, Dept Pathophysiol Sci, Kanazawa, Ishikawa 92011, Japan
[3] Ishida Clin, Tosu, Saga, Japan
[4] Sasaguri Hosp, Kasuya, Japan
关键词
AGEs; oxidative stress; diabetes; statin;
D O I
10.1007/s10238-006-0115-6
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页码:191 / 193
页数:3
相关论文
共 8 条
[1]   Atorvastatin and gemfibrozil metabolites, but not the parent drugs, are potent antioxidants against lipoprotein oxidation [J].
Aviram, M ;
Rosenblat, M ;
Bisgaier, CL ;
Newton, RS .
ATHEROSCLEROSIS, 1998, 138 (02) :271-280
[2]   Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial [J].
Colhoun, HM ;
Betteridge, DJ ;
Durrington, PN ;
Hitman, GA ;
Neil, HAW ;
Livingstone, SJ ;
Thomason, MJ ;
Mackness, MI ;
Charlton-Menys, V ;
Fuller, JH .
LANCET, 2004, 364 (9435) :685-696
[3]   Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage [J].
Nishikawa, T ;
Edelstein, D ;
Du, XL ;
Yamagishi, S ;
Matsumura, T ;
Kaneda, Y ;
Yorek, MA ;
Beebe, D ;
Oates, PJ ;
Hammes, HP ;
Giardino, I ;
Brownlee, M .
NATURE, 2000, 404 (6779) :787-790
[4]  
Packard CJ, 1998, CIRCULATION, V97, P1440
[5]   Atorvastatin and cardiovascular protection: a review and comparison of recent clinical trials [J].
Ray, KK ;
Cannon, CP .
EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (06) :915-927
[6]   Immunological evidence that non-carboxymethyllysine advanced glycation end-products are produced from short chain sugars and dicarbonyl compounds in vivo [J].
Takeuchi, M ;
Makita, Z ;
Bucala, R ;
Suzuki, T ;
Koikie, T ;
Kameda, Y .
MOLECULAR MEDICINE, 2000, 6 (02) :114-125
[7]   Protein glycation - A firm link to endothelial cell dysfunction [J].
Wautier, JL ;
Schmidt, AM .
CIRCULATION RESEARCH, 2004, 95 (03) :233-238
[8]   Diabetic vascular complications: Pathophysiology, biochemical basis and potential therapeutic strategy [J].
Yamagishi, S ;
Imaizumi, T .
CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (18) :2279-2299